Immco Diagnostics 2513
Immco Diagnostics 2513 is a Class II device made by Immco Diagnostics, Inc., listed in FDA GUDID since 27 Oct 2016 (UDI-DI 00845714002939), registry data as of 23 Oct 2026.
Listed
Valid until
Not applicable
FDA recalls
Not checked
Documents
None
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00845714002939 | Date27 Oct 2016 | StatusListed |
Official records
- AccessGUDID record 00845714002939
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Trade name
- Immco Diagnostics
- Generic name
- Immunohistochemistry chromogenic substrate IVD, kit, enzyme immunohistochemistry
- Model / Ref / Catalog
- 2513
- Primary DI / UDI-DI
- 00845714002939
- FDA product code
- MSV, LJM
- GMDN term
- Immunohistochemistry chromogenic substrate IVD, kit, enzyme immunohistochemistry
- Device class
- Class II
- Regulation number
- 866.5660, 866.5100
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code MSV (System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)).
- REAADS ANTI-BETA 2 GLYCOPROTEIN I IGM TEST KIT by Corgenix, Inc.
- QUANTA LITE B2GPI IGM by Inova Diagnostics. Inc.
- QAB2A IGG ELISA KIT by Cheshire Diagnostics, Ltd.
- HEMOSIL ACUSTAR ANTI-B2 GLYCOPROTEIN-I; IGG, IGM, IGG CONTROLS, IGM CONTROLS by INSTRUMENTATION LABORATORY COMPANY
- BINDAZYME ANTI-B2 GP1 IGG EIA TEST KIT by The Binding Site, Ltd.
- REAADS ANTI-BETA 2 GLYCOPROTEIN I IGA TEST KIT by Corgenix, Inc.
- VIRGO B2 GLYCOPROTEIN I IGA ANTIBODY KIT by HEMAGEN DIAGNOSTICS, INC.
- VARELISA B2 GLYCOPROTEIN I IGG ANTIBODIES, MODELS 18748 AND 18796 by Pharmacia Deutschland GmbH
- BINDAZYME ANTI-B2 SCREEN EIA TEST KIT. by The Binding Site, Ltd.
- VARELISA B2 GLYCOPROTEIN I ANTIBODIES SCREEN, MODELS 19048 AND 19096 by Pharmacia Deutschland GmbH